New device aims to prevent clots in stroke patients
NCT ID NCT06477016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new device called OsciPulse that rapidly compresses the calves to improve blood flow and reduce the risk of blood clots in people hospitalized after a stroke. About 40 adults with leg weakness will be randomly assigned to receive either OsciPulse or standard compression therapy. The main goal is to see if OsciPulse lowers a blood-clot marker called D-dimer more than standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OsciPulse device (non-invasive leg compression)
What this could lead to
If it works, this could offer a better way to prevent dangerous blood clots in stroke patients who cannot move their legs.
What could go wrong
This is a very small pilot study with only 40 people, so results may not apply widely. The device may be no better than standard compression or may be uncomfortable for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HUP Neurology Dept. of Stroke and Neurocritical Care- University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States